Cronos Group Stock Price, News & Analysis (CVE:MJN)

C$3.91 0.01 (0.26 %)
(As of 11/18/2017 04:00 PM ET)
Previous CloseC$3.91
Today's RangeC$4.18 - C$3.80
52-Week RangeC$1.58 - C$4.45
Volume755,600 shs
Average Volume631,998 shs
Market CapitalizationC$562.16 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Cronos Group (CVE:MJN)

Cronos Group logoCronos Group, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations (“MMPR”). The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group was incorporated in January, 2013 and is based in Toronto, Canada.


Industry, Sector and Symbol:
  • Industry: Biotechnology
  • Sub-Industry: Cannabis
  • Sector: Healthcare
  • Symbol: CVE:MJN
  • CUSIP: N/A
  • Web: thecronosgroup.com
Profitability:
  • Trailing EPS: C$0.03
  • Net Margins: 27.17%
  • Return on Equity: 1.38%
  • Return on Assets: 1.23%
Misc:
  • Outstanding Shares: 133,142,000
 

Frequently Asked Questions for Cronos Group (CVE:MJN)

What is Cronos Group's stock symbol?

Cronos Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MJN."

When will Cronos Group make its next earnings announcement?

Cronos Group is scheduled to release their next quarterly earnings announcement on Tuesday, December, 5th 2017. View Earnings Estimates for Cronos Group.

Where is Cronos Group's stock going? Where will Cronos Group's stock price be in 2017?

2 brokers have issued 1 year price targets for Cronos Group's shares. Their predictions range from C$3.00 to C$3.00. On average, they expect Cronos Group's share price to reach C$3.00 in the next twelve months. View Analyst Ratings for Cronos Group.

Who are some of Cronos Group's key competitors?

Who are Cronos Group's key executives?

Cronos Group's management team includes the folowing people:

  • Michael Ryan Gorenstein, President, Chief Executive Officer, Vice Chairman of the Board, Corporate Secretary
  • William Hilson, Chief Financial Officer
  • Jason Adler, Director
  • Ryan Roebuck, Director
  • Alan Mark Friedman, Independent Director (Age 45)
  • Michael Howard Krestell, Independent Director

How do I buy Cronos Group stock?

Shares of Cronos Group and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Cronos Group's stock price today?

One share of Cronos Group stock can currently be purchased for approximately C$3.91.

How big of a company is Cronos Group?

Cronos Group has a market capitalization of C$562.16 million.

How can I contact Cronos Group?

Cronos Group's mailing address is 76 Stafford St Suite 302, TORONTO, ON M6J 2S1, Canada. The company can be reached via phone at +1-416-5040004.


MarketBeat Community Rating for Cronos Group (CVE MJN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  69
MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Cronos Group (CVE:MJN)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: C$3.00

Consensus Price Target History for Cronos Group (CVE:MJN)

Price Target History for Cronos Group (CVE:MJN)

Analysts' Ratings History for Cronos Group (CVE:MJN)

Show:
DateFirmActionRatingPrice TargetDetails
7/5/2017Canaccord GenuitySet Price TargetSpeculative BuyC$3.00View Rating Details
2/10/2017Beacon SecuritiesReiterated RatingBuyView Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History for Cronos Group (CVE:MJN)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Cronos Group (CVE:MJN)
2017 EPS Consensus Estimate: ($0.01)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.01)($0.01)($0.01)
Q1 20191$0.03$0.03$0.03
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cronos Group (CVE:MJN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Cronos Group (CVE MJN)

Insider Trades by Quarter for Cronos Group (CVE:MJN)

Insider Trades by Quarter for Cronos Group (CVE MJN)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2017Michael Ryan GorensteinDirectorBuy5,000C$2.24C$11,200.00
9/7/2017William Lawrence HilsonInsiderBuy11,000C$2.25C$24,750.00
6/15/2017Michael Howard KrestellDirectorSell83,700C$1.78C$148,986.00
6/7/2017Jason Marc AdlerInsiderBuy5,000C$1.77C$8,850.00
6/6/2017Jason Marc AdlerInsiderBuy80,000C$1.73C$138,400.00
6/5/2017William Lawrence HilsonInsiderBuy22,000C$1.91C$42,020.00
5/21/2015Steven G IsenbergDirectorBuy20,000C$0.50C$10,000.00
5/19/2015Steven G IsenbergDirectorBuy55,000C$0.50C$27,500.00
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cronos Group (CVE MJN)

Source:
DateHeadline
Why Growing Marijuana In Israel Is A Good Idea: Cronos Group CEO Explains New Joint Venture - BenzingaWhy Growing Marijuana In Israel Is A Good Idea: Cronos Group CEO Explains New Joint Venture - Benzinga
www.benzinga.com - September 25 at 7:26 PM
Why Growing Marijuana In Israel Is A Good Idea: Cronos Group CEO Explains New Joint VentureWhy Growing Marijuana In Israel Is A Good Idea: Cronos Group CEO Explains New Joint Venture
feeds.benzinga.com - September 25 at 4:49 PM
The Sky Is The Limit For Canada’s Newest IndustryThe Sky Is The Limit For Canada’s Newest Industry
www.baystreet.ca - September 19 at 3:15 AM
Cronos Group Inc (MJN) Director Buys C$11,200.00 in StockCronos Group Inc (MJN) Director Buys C$11,200.00 in Stock
www.americanbankingnews.com - September 7 at 8:30 PM
Insider Buying: Cronos Group Inc (MJN) Insider Purchases 11,000 Shares of StockInsider Buying: Cronos Group Inc (MJN) Insider Purchases 11,000 Shares of Stock
www.americanbankingnews.com - September 7 at 8:28 PM
Cronos Group Files Q2 2017 Financial Results and Provides Operational UpdateCronos Group Files Q2 2017 Financial Results and Provides Operational Update
www.benzinga.com - August 30 at 6:36 AM
Bigger Than Bingo: Seminole Chief Jim Billie On His New Cannabis Advisory Firm And A Tax-Free Environment - BenzingaBigger Than Bingo: Seminole Chief Jim Billie On His New Cannabis Advisory Firm And A Tax-Free Environment - Benzinga
www.benzinga.com - July 20 at 1:13 AM
Cronos Group Inc (CVE:MJN) Given a C$3.00 Price Target at Canaccord GenuityCronos Group Inc (CVE:MJN) Given a C$3.00 Price Target at Canaccord Genuity
www.americanbankingnews.com - July 5 at 2:32 PM
Cronos Group Files Q1 2017 Financial ResultsCronos Group Files Q1 2017 Financial Results
www.benzinga.com - June 1 at 9:26 AM
Cronos Grants Stock Options - MarketWatchCronos Grants Stock Options - MarketWatch
www.marketwatch.com - April 13 at 8:35 AM
Cronos Grants Stock OptionsCronos Grants Stock Options
www.marketwatch.com - April 12 at 7:30 PM
Cronos Execs On Marijuana Legalization In Canada And How It Affects The Co: Market Could Be Ready To Go By 2019 - BenzingaCronos Execs On Marijuana Legalization In Canada And How It Affects The Co: Market Could Be Ready To Go By 2019 - Benzinga
www.benzinga.com - March 21 at 11:30 PM
Cronos Group Execs Talk About Cannabis Co., Recent Bought Deal And Expansion Plans - BenzingaCronos Group Execs Talk About Cannabis Co., Recent 'Bought Deal' And Expansion Plans - Benzinga
www.benzinga.com - March 20 at 10:16 AM

Social Media

Financials

Financials are not available for this stock.

Chart

Cronos Group (CVE MJN) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.